PEOPLE - Biocomposites makes appointment:
This article was originally published in Clinica
Executive Summary
Biocomposites, a manufacturer of synthetic calcium composite devices for tissue regeneration, has named Simon Zhou as commercial director of the firm's Shanghai division. Dr Zhou's experience in orthopaedic bone grafting has made him a key member of Biocomposite's clinical and histological studies group. The Staffordshire, UK-based company has also announced the appointment of Phillip Pleace as UK market development manager. Mr Pleace previously held positions within the Biomet and Stryker corporations.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.